Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to investigate the relationship between urinary incontinence severity and surface electromyography (EMG) findings in women with multiple sclerosis. It will also examine the association of urinary incontinence with disability, quality of life, physical activity, and fatigue.
This study investigates the relationship between urinary incontinence (UI) severity and pelvic floor muscle activity in women with multiple sclerosis (MS). UI is common in MS and negatively affects quality of life, physical activity, and social participation. The study also explores how UI severity is associated with disability, fatigue, and overall quality of life.
Participants' demographic and clinical information, including age, disease duration, MS type, and disability level (measured by the Expanded Disability Status Scale, EDSS), will be recorded. Standardized questionnaires will assess urinary symptoms, their impact on daily life, physical activity, and fatigue. Pelvic floor muscle activity will be evaluated using surface electromyography (EMG) with biofeedback, conducted by trained physiotherapists.
The study will be conducted at the Pelvic Floor Health Center and is planned as a cross-sectional study. All assessments, including questionnaires and EMG measurements, are expected to take approximately 45 minutes per participant. Findings from this study aim to improve understanding of UI in women with MS and guide future interventions.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Observational Group | Participants will be observed for EMG activity, fatigue, physical activity, and urinary incontinence symptoms. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Pelvic floor muscle activity with surface EMG | Evaluated using biofeedback-assisted surface EMG. Metrics recorded include mean EMG activity during contraction and rest phases, standard deviation of EMG activity, peak and minimum EMG values, contraction onset, and relaxation times | baseline |
| Measure | Description | Time Frame |
|---|---|---|
| International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) | Assesses severity and impact of urinary incontinence | baseline |
| Incontinence Impact Questionnaire (IIQ-7) | Evaluates the effect of urinary incontinence on quality of life |
Not provided
Inclusion Criteria:
Diagnosis of multiple sclerosis (MS) according to the 2017 revised McDonald criteria.
Female patients aged 30-50 years (age range with higher prevalence of urinary incontinence in MS).
Experiencing urinary incontinence (UI) symptoms according to the International Continence Society (ICS) definition.
EDSS (Expanded Disability Status Scale) score below 6.5.
Patients with no communication difficulties. -
Exclusion Criteria:
MS patients who do not provide consent to participate in the study.
MS patients who have had a medication change within the last 6 months.
Pregnant MS patients.
History of vaginal or cesarean delivery within the last 6 months.
Pelvic organ prolapse.
Urinary tract infection
-
Study limited to biological females due to pelvic floor muscle assessment
The study will include female patients with multiple sclerosis (MS) aged 30-50 years, diagnosed according to the 2017 revised McDonald criteria, who experience urinary incontinence symptoms according to the International Continence Society (ICS) definition and have an EDSS score below 6.5. Participants must be able to communicate effectively. Patients who do not provide consent, have had a medication change within the last 6 months, are pregnant, have had a vaginal or cesarean delivery within the last 6 months, have pelvic organ prolapse, or have a urinary tract infection will be excluded.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Büşra Aydın Erkılıç, MSc | Contact | 905062214052 | bsrr.aydinn@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Istanbul, Prof. Dr. Cemil Taşçıoğlu City Hospital, Turkey | Recruiting | Istanbul | Turkey (Türkiye) |
Individual participant data (IPD) from this study will not be shared with other researchers.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| D014549 | Urinary Incontinence |
| D005221 | Fatigue |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| baseline |
| International Physical Activity Questionnaire (IPAQ) | Assesses participants' physical activity levels | baseline |
| Fatigue Severity Scale (FSS) | Measures severity of fatigue experienced by participants | baseline |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001519 | Behavior |